These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 32069066)

  • 21. Switching from Suspend-Before-Low Insulin Pump Technology to a Hybrid Closed-Loop System Improves Glucose Control and Reduces Glucose Variability: A Retrospective Observational Case-Control Study.
    Lepore G; Scaranna C; Corsi A; Dodesini AR; Trevisan R
    Diabetes Technol Ther; 2020 Apr; 22(4):321-325. PubMed ID: 31617752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perceptions and experiences of adult patients with type 1 diabetes using continuous subcutaneous insulin infusion therapy: Results of an online survey.
    Taleb N; Messier V; Ott-Braschi S; Ardilouze JL; Rabasa-Lhoret R
    Diabetes Res Clin Pract; 2018 Oct; 144():42-50. PubMed ID: 30077691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
    Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
    BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting the optimal basal insulin infusion pattern in children and adolescents on insulin pumps.
    Holterhus PM; Bokelmann J; Riepe F; Heidtmann B; Wagner V; Rami-Merhar B; Kapellen T; Raile K; Quester W; Holl RW;
    Diabetes Care; 2013 Jun; 36(6):1507-11. PubMed ID: 23404300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of flash glucose monitoring with real time continuous glucose monitoring in children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion.
    Massa GG; Gys I; Bevilacqua E; Wijnands A; Zeevaert R
    Diabetes Res Clin Pract; 2019 Jun; 152():111-118. PubMed ID: 31121275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [From insulin pump and continuous glucose monitoring to the artificial pancreas].
    Apablaza P; Soto N; Codner E
    Rev Med Chil; 2017 May; 145(5):630-640. PubMed ID: 28898340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experiences of continuous subcutaneous insulin infusion in pregnant women with type 1 diabetes during delivery from four Italian centers: a retrospective observational study.
    Fresa R; Visalli N; Di Blasi V; Cavallaro V; Ansaldi E; Trifoglio O; Abbruzzese S; Bongiovanni M; Agrusta M; Napoli A
    Diabetes Technol Ther; 2013 Apr; 15(4):328-34. PubMed ID: 23537417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel methodology to determine the accuracy of the OmniPod insulin pump: a key component of the artificial pancreas system.
    Zisser H; Breton M; Dassau E; Markova K; Bevier W; Seborg D; Kovatchev B
    J Diabetes Sci Technol; 2011 Nov; 5(6):1509-18. PubMed ID: 22226273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative Dose Accuracy of Durable and Patch Insulin Pumps Under Laboratory Conditions.
    Laubner K; Singler E; Straetener J; Siegmund T; Päth G; Seufert J
    Diabetes Technol Ther; 2019 Jul; 21(7):371-378. PubMed ID: 31149838
    [No Abstract]   [Full Text] [Related]  

  • 32. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
    Jarosz-Chobot P
    Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the Accuracy of Current Tubeless Pumps for Continuous Subcutaneous Insulin Infusion.
    Ziegler R; Oliver N; Waldenmaier D; Mende J; Haug C; Freckmann G
    Diabetes Technol Ther; 2021 May; 23(5):350-357. PubMed ID: 33210949
    [No Abstract]   [Full Text] [Related]  

  • 34. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].
    Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
    Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL
    Diabetologia; 2015 May; 58(5):862-70. PubMed ID: 25784563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
    Rodbard D
    Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin Sensitivity Index-Based Optimization of Insulin to Carbohydrate Ratio: In Silico Study Shows Efficacious Protection Against Hypoglycemic Events Caused by Suboptimal Therapy.
    Schiavon M; Dalla Man C; Cobelli C
    Diabetes Technol Ther; 2018 Feb; 20(2):98-105. PubMed ID: 29355438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin pump use compared with intravenous insulin during labour and delivery: the INSPIRED observational cohort study.
    Drever E; Tomlinson G; Bai AD; Feig DS
    Diabet Med; 2016 Sep; 33(9):1253-9. PubMed ID: 26927202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin pump therapy in adults.
    Didangelos T; Iliadis F
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S109-13. PubMed ID: 21864741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of infusion rate and indwelling time on tissue resistance pressure in small-volume subcutaneous infusion like in continuous subcutaneous insulin infusion.
    Patte C; Pleus S; Wiegel C; Schiltges G; Jendrike N; Haug C; Freckmann G
    Diabetes Technol Ther; 2013 Apr; 15(4):289-94. PubMed ID: 23427865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.